2024 ASCO® Annual Meeting Insights Hub

Meeting coverage & Vumedi’s exclusive highlights, all in one place.

 

ASCO® 2024 Insights: "The GIANT Trial (EA2186) - Gem & nab-Paclitaxel vs. 5-FU, Leucovorin, & Liposomal Irinotecan in Older Pts With Treatment-Naïve Metastatic Pancreatic Cancer"

704 views
June 7, 2024

Chapters

Overview & Significance of GIANT Study

00:00

Study Design & Patient Demographics

01:45

Accrual Challenges & Baseline Characteristics

04:04

Primary & Secondary Endpoint Results

06:36

Conclusions & Acknowledgments

10:50

0 Comments
Login to view comments. Click here to Login